AFTER FRANCE AND BENELUX, VIVACTIS CONQUERS SWITZERLAND!

Reminder: incorporation of the Vivactis group within the group Newton 21 had as strategy to be a preface to its further internationalization. So, from March 2008 the Vivactis group could rely, except of its historical base in France, on a fastgrowing benchmark player of the Belgian market, SPIN Healthcare, afterwards renamed as Vivactis Benelux. Moreover, taking opportunity of existing company of the Newton 21 group in Breda (the Netherlands) it was decided to expand Vivactis brand activities to the Netherlands. Already after only several months of the partnership with the group Newton 21, Vivactis could extend its offer on three markets. Since October 2008 a new market opens to the group operating under the brand Vivactis: Switzerland. From now on the group will operate under the name Vivactis Switzerland from Lausanne and Geneva. The doctor Thierry Weber, manager of the new company, brings to Vivactis Switzerland customers, turnover and networks that he develops since four years in Switzerland. Frederick Gonda, co-founder and successful developer (200.000 Euro of EBITDA in two years!) of SPIN Healthcare in Belgium, will assist doctor Thierry Weber with the objective to make Vivactis Switzerland the leader of the Swiss market of Healthcare and well-being communication. The offer of Vivactis Switzerland will be very close to that of Vivactis put together: the global offer will cover the ethic market, the market of OTC and institutional communication on one hand; and the markets of well-being and fresh food products on the other hand. In Spain, while waiting for the creation of Vivactis’ company previewed in some months, Newton 21 Barcelona proposes the Vivactis’ global offer of healthcare services. For instance, Newton 21 Barcelona developed very important activity in healthcare communication, more particularly in health education for citizens (www.thaoweb.com). Therefore today Vivactis delivers its wide range of services on 5 European markets. This result has been achieved only after 6 months of the partnership with Newton 21!
	Note: The results of the third quarter confirm the tendency announced after two quarters:
	The turnover is quasi stable in comparison with 2007 and reaches 20 million euros. The operational result is 1,7 million euros while for the same period of 2007 it showed 0, 468 million euros. The gross margin shows a spectacular progression of 45% (22 % for the same period of 2007).